METACARE Past Earnings Performance
Past criteria checks 0/6
METACARE's earnings have been declining at an average annual rate of -32%, while the Healthcare industry saw earnings growing at 12.4% annually. Revenues have been declining at an average rate of 2% per year.
Key information
-32.0%
Earnings growth rate
-10.2%
EPS growth rate
| Healthcare Industry Growth | 34.2% |
| Revenue growth rate | -2.0% |
| Return on equity | -19.6% |
| Net Margin | -19.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 05
Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%
Mar 07There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release
Mar 22What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 31
Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?
Dec 25Revenue & Expenses Breakdown
How METACARE makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 56,967 | -10,973 | 13,091 | 1,182 |
| 31 Mar 24 | 56,365 | 1,277 | 13,008 | 1,182 |
| 31 Dec 23 | 55,750 | -14,540 | 12,657 | 1,182 |
| 30 Sep 23 | 16,845 | -21,919 | 3,611 | 0 |
| 30 Jun 23 | 17,385 | -27,708 | 3,912 | 0 |
| 31 Mar 23 | 18,084 | -47,281 | 3,960 | 0 |
| 31 Dec 22 | 19,098 | -49,555 | 4,709 | 0 |
| 30 Sep 22 | 17,464 | -28,004 | 5,029 | 0 |
| 30 Jun 22 | 20,071 | -21,221 | 4,538 | 0 |
| 31 Mar 22 | 22,268 | 8,437 | 5,713 | 0 |
| 31 Dec 21 | 18,613 | 9,816 | 5,172 | 0 |
| 30 Sep 21 | 4,678 | 14,484 | 2,682 | 0 |
| 30 Jun 21 | 3,228 | 21,802 | 2,972 | 0 |
| 31 Mar 21 | 4,351 | 12,292 | 1,932 | -65 |
| 31 Dec 20 | 6,621 | 12,429 | 2,242 | 0 |
| 30 Sep 20 | 34,628 | 6,560 | 3,572 | -5 |
| 30 Jun 20 | 53,269 | 2,035 | 3,598 | -5 |
| 31 Mar 20 | 53,886 | -3,595 | 3,806 | 54 |
| 31 Dec 19 | 56,155 | -4,039 | 4,403 | 17 |
| 30 Sep 19 | 49,406 | -11,415 | 6,199 | 57 |
| 30 Jun 19 | 32,619 | -11,494 | 6,974 | 77 |
| 31 Mar 19 | 30,674 | -11,627 | 7,274 | 68 |
| 31 Dec 18 | 33,588 | -11,178 | 9,151 | 109 |
| 30 Sep 18 | 39,985 | -2,205 | 9,027 | 265 |
| 30 Jun 18 | 42,752 | -3,035 | 9,675 | 256 |
| 31 Mar 18 | 42,345 | -3,289 | 9,518 | 268 |
| 31 Dec 17 | 35,586 | -2,745 | 6,794 | 281 |
| 30 Sep 17 | 20,846 | -8,299 | 6,844 | 111 |
| 30 Jun 17 | 12,166 | -7,978 | 5,204 | 178 |
| 31 Mar 17 | 7,082 | -6,762 | 4,552 | 226 |
| 31 Dec 16 | 8,312 | -6,943 | 4,783 | 193 |
| 30 Sep 16 | 10,412 | -5,320 | 4,575 | 223 |
| 30 Jun 16 | 11,358 | -5,609 | 5,903 | 216 |
| 31 Mar 16 | 12,365 | -6,985 | 6,498 | 224 |
| 31 Dec 15 | 11,451 | -7,594 | 7,381 | 228 |
| 30 Sep 15 | 11,622 | -11,694 | 8,372 | 274 |
| 30 Jun 15 | 12,908 | -10,495 | 7,902 | 331 |
| 31 Mar 15 | 12,390 | -9,377 | 7,972 | 343 |
| 31 Dec 14 | 11,762 | -8,846 | 7,753 | 372 |
| 30 Sep 14 | 12,021 | -5,259 | 8,119 | 350 |
| 30 Jun 14 | 8,865 | -5,358 | 7,415 | 247 |
| 31 Mar 14 | 9,198 | -5,028 | 7,224 | 213 |
| 31 Dec 13 | 12,466 | -4,563 | 6,808 | 157 |
Quality Earnings: A118000 is currently unprofitable.
Growing Profit Margin: A118000 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A118000 is unprofitable, and losses have increased over the past 5 years at a rate of 32% per year.
Accelerating Growth: Unable to compare A118000's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A118000 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.2%).
Return on Equity
High ROE: A118000 has a negative Return on Equity (-19.64%), as it is currently unprofitable.